Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Meek

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
Scottish Medical Journal|March 19, 2009
Direct to consumer advertising via the Internet, a study of hip resurfacingB Ogunwale, J Clarke, D Young, et al.
The Bone & Joint Journal|February 1, 2023
Is it time to reconsider the use of hydrogen peroxide in hip and knee arthroplasty?Omer M Farhan-Alanie, Ian W Kennedy, R M D Meek, et al.
Clinical Medicine & Research|July 2, 2008
Late dislocation after total hip arthroplastyR M D Meek, D B Allan, G McPhillips, et al.
The Bone & Joint Journal|April 8, 2017
Can we predict which dysplastic hips will require acetabular augmentation during total hip arthroplasty based on pre-operative radiographs?A G Marsh, A Nisar, M El Refai, et al.
Clinical Orthopaedics and Related Research|May 5, 2006
Epidemiology of dislocation after total hip arthroplastyR M D Meek, D B Allan, G McPhillips, et al.
European Journal of Immunology|March 1, 1989
Molecular characterization of the VH region of murine autoantibodies from neonatal and adult BALB/c miceM Sollazzo, C A Hasemann, K D Meek, et al.
Journal of Medicinal Chemistry|July 1, 1988
cis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1 H)-one , a potent inhibitor of mammalian dihydroorotaseJ L Adams, T D Meek, S M Mong, et al.
The Journal of Bone and Joint Surgery. British Volume|August 28, 2010
Electrocautery of the patellar rim in primary total knee replacement: beneficial or unnecessary?S Gupta, A Augustine, L Horey, et al.
The Anatomical Record|October 1, 1991
Fine structure of the human synovial lining cell in osteoarthritis: its prominent cytoskeletonW D Meek, B T Raber, O M McClain, et al.
Pharmacy Practice Management Quarterly|November 11, 1999
Cost-offset analysis of aprotinin in high-risk coronary artery bypassP D Meek, P H Vlasses, M E Sura, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
Scottish Medical Journal|March 19, 2009
Direct to consumer advertising via the Internet, a study of hip resurfacingB Ogunwale, J Clarke, D Young, et al.
The Bone & Joint Journal|February 1, 2023
Is it time to reconsider the use of hydrogen peroxide in hip and knee arthroplasty?Omer M Farhan-Alanie, Ian W Kennedy, R M D Meek, et al.
Clinical Medicine & Research|July 2, 2008
Late dislocation after total hip arthroplastyR M D Meek, D B Allan, G McPhillips, et al.
The Bone & Joint Journal|April 8, 2017
Can we predict which dysplastic hips will require acetabular augmentation during total hip arthroplasty based on pre-operative radiographs?A G Marsh, A Nisar, M El Refai, et al.
Clinical Orthopaedics and Related Research|May 5, 2006
Epidemiology of dislocation after total hip arthroplastyR M D Meek, D B Allan, G McPhillips, et al.
European Journal of Immunology|March 1, 1989
Molecular characterization of the VH region of murine autoantibodies from neonatal and adult BALB/c miceM Sollazzo, C A Hasemann, K D Meek, et al.
Journal of Medicinal Chemistry|July 1, 1988
cis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1 H)-one , a potent inhibitor of mammalian dihydroorotaseJ L Adams, T D Meek, S M Mong, et al.
The Journal of Bone and Joint Surgery. British Volume|August 28, 2010
Electrocautery of the patellar rim in primary total knee replacement: beneficial or unnecessary?S Gupta, A Augustine, L Horey, et al.
The Anatomical Record|October 1, 1991
Fine structure of the human synovial lining cell in osteoarthritis: its prominent cytoskeletonW D Meek, B T Raber, O M McClain, et al.
Pharmacy Practice Management Quarterly|November 11, 1999
Cost-offset analysis of aprotinin in high-risk coronary artery bypassP D Meek, P H Vlasses, M E Sura, et al.
Pageof 21